These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6912579)

  • 1. The participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. II. Participation of PGF2 alpha in the action of kinins on the central dopaminergic system.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):357-70. PubMed ID: 6912579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. III. Participation of PGE1 in the action of kinins on the central dopaminergic system.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):371-94. PubMed ID: 6912580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. I. The action of kinins on the central dopaminergic system after pretreatment with indomethacin.
    Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1980; 32(3):343-56. PubMed ID: 6912578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
    Borawska M; Wiśniewski K
    Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of bradykinin with dopaminergic receptors in the CNS.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1977; 29(3):301-11. PubMed ID: 887505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the central activity of kinins.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):655-9. PubMed ID: 1012986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
    Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(5):473-80. PubMed ID: 575732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism.
    Kuczenski R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):135-42. PubMed ID: 6109012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of kinins on amphetamine activity.
    Moniuszko-Jakoniuk J; Kościelak M
    Pol J Pharmacol Pharm; 1976; 28(6):661-5. PubMed ID: 1012987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal cadmium and ethanol increase amphetamine-evoked dopamine release in rat striatum.
    Nowak P; Dabrowska J; Bortel A; Izabela B; Kostrzewa RM; Brus R
    Neurotoxicol Teratol; 2006; 28(5):563-72. PubMed ID: 17005368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidopaminergic properties of yohimbine.
    Scatton B; Zivkovic B; Dedek J
    J Pharmacol Exp Ther; 1980 Nov; 215(2):494-9. PubMed ID: 7192314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations of the mechanism of central action of kinins.
    Moniuszko-Jakoniuk J; Wisniewski K; Koscielak M
    Psychopharmacology (Berl); 1976 Nov; 50(2):181-6. PubMed ID: 12529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central neurotropic activity of homovanillic acid.
    Kleinrok Z; Zarkowski AM
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.